Dollars for Profs
Dig Into University Researchers' Outside Income and Conflicts of Interest
Published Dec. 6, 2019
This database was last updated in December 2019 and should only be used as a historical snapshot. There may be new or amended records not reflected here.
Conflict of Interest
Institutions must file significant disclosures to the National Institutes of Health if they determine financial relationships could affect the design, conduct or reporting of the NIH-funded research. The NIH provided us with their entire financial conflict of interest database, with filings from 2012 through 2019.
Should you be removed from our database? Contact us at [email protected]. Read more below.
Michael Messod Abecassis
Northwestern University at Chicago, Department: Surgery
Should you be removed from our database? Contact us at [email protected]. Read more below.
Transplant Genomics
Equity Interest - Non-publicly traded entity ( e.g., stock, stock option, or other ownership interest)
The research is related to the focus of an entity in which Professor Abecassis has significant financial interests. Professor Abecassis is a founder of Transplant Genomics (TGI) and holds equity interests in and receives compensation for consulting from this non-publicly-traded entity.
TGI’s objective is to discover robust molecular signatures indicative of individual patient graft status, prognosis or response to specific immunosuppressant regimens to complement existing immunohistological analysis, which will enable precise patient-centric therapeutic intervention and improved transplant outcomes.
This research focusing on biomarker profiling in the management of transplant patients aims to integrate molecular diagnostics into clinical practice, demonstrating their value in the management of patients following kidney transplantation (KT).
This entity has licensing agreements and exclusive options to intellectual property developed in this area of research. The close intersection of this research and Professor Abecassis’s TGI interests result in the perception of a conflict of interest in this area of research that should be managed.
Effectiveness, Safety and Value of Integrating Molecular Diagnostics into the Post-Transplant Management of Kidney Transplant Recipients - The Next Frontier of Biomarker Research
The promise of precision medicine will be achieved when molecular diagnostics detect actionable differences operating in individual patients early enough to inform therapy and change clinical outcomes. Long-term graft outcomes following kidney transplantation (KT) have not improved in 3 decades, despite better immunosuppression (IS), lower rates of acute rejection, and improved short- and medium-term clinical outcomes. We propose a randomized clinical trial that will demonstrate the effectiveness, safety and value of integrating predictive molecular biomarkers into post-KT clinical practice and management, improving long- term outcomes, and providing novel mechanistic insights into chronic rejection and poor long-term outcomes.
Filed on August 03, 2015.
Tell us what you know about Michael Messod Abecassis's disclosure
We're still reporting about conflicts of interest. Is there something you'd like to tell us about this disclosure?
Michael Messod Abecassis filed other conflict of interest disclosures with the NIH:
| Name | Institution | Type | Company | Disclosed Value |
|---|---|---|---|---|
| Michael Messod Abecassis | Northwestern University at Chicago | Conflict of Interest | Transplant Genomics | $40,000 - $59,999 |
Notes: When a more specific filing date is not available for an individual financial disclosure or conflict of interest form, we use the year the form was filed. If the year was not disclosed, we report the range of years covered by our public records requests. In a few cases, a start date was provided instead of a filing date. In those cases, we use the start date instead.
Fewer than 10% of records from the University of Florida and fewer than 1% of records from the University of Texas system were removed because they did not contain enough information.
ProPublica obtained additional financial disclosures and conflict of interest forms that we have not yet digitized and added to the database. You can download those disclosures in the ProPublica Data Store.